Abstract
BackgroundAcne vulgaris is a common skin disease. Pharmacological modalities for treatment are proven to be efficacious but have limitations. Light therapy for acne vulgaris has shown promise in previous studies. This case report and its accompanying images show how a novel approach of visually augmented high fluence light therapy has been used to good effect.Case presentationA 26-year-old Caucasian woman with acne vulgaris resistant to treatment with topical therapy underwent three sessions of combination potassium titanyl phosphate laser (532 nm)/neodymium-doped: yttrium aluminum garnet laser (1064 nm) light therapy with visually augmented narrow spot size and high fluence. A 73% reduction in total inflammatory lesions was evident 6 months after the initial treatment.ConclusionsThis case report illustrates that there may be utility in this novel approach of narrow spot size, magnification-assisted, high fluence targeted combination laser therapy for inflammatory acne.
Highlights
Acne vulgaris is a common skin disease
Systemic retinoids are teratogenic and have systemic side effects, while non-compliance is an issue with topical treatment
The following case illustrates an approach to using phototherapy for acne that uses a novel combination of narrow spot size wavelengths with high energy level phototherapy under visual magnification to achieve a 73% reduction in inflammatory lesions
Summary
Acne vulgaris is a common skin disease affecting 90% of people at some time in their lives, to varying degrees. Case presentation A 26-year-old Caucasian woman with Fitzpatrick skin type II presented with facial acne vulgaris She had a slim build, no evidence of hirsutism, and no significant past medical or family history. Yazdi et al Journal of Medical Case Reports (2017) 11:316 lesions (from 37 to 10) was evident on completion of the three applications when our patient was reviewed 6 months after the initial treatment (Fig. 2). This represented a reduction in acne severity from severe (grade 4) to mild (grade 2) on the IGA scale. She reported that she was very satisfied with the outcome of the treatment
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
